J M Puig
Overview
Explore the profile of J M Puig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortega F, Puig J, Paul-Ramos F, Salcedo M, Bravo J, de la Cruz J, et al.
Transplant Proc
. 2014 Dec;
46(10):3629-36.
PMID: 25498101
A significant proportion of transplant patients undergoing immunosuppressant therapy experience gastrointestinal (GI) symptoms. The SIGIT-QoL is a brief instrument developed to measure adverse gastrointestinal effects on patients' health-related quality of...
2.
Crespo M, Mir M, Marin M, Hurtado S, Estadella C, Guri X, et al.
Transplant Proc
. 2009 Sep;
41(6):2115-7.
PMID: 19715848
Introduction: Advagraf is a new modified-release once-daily formulation of tacrolimus with a similar efficacy and safety profile to twice-daily tacrolimus (Prograf) according to clinical trials. Few data are published about...
3.
4.
Soler M, Mir M, Rodriguez E, Orfila A, Munne A, Vazquez S, et al.
Transplant Proc
. 2006 Jan;
37(9):3705-9.
PMID: 16386512
Background: IgA nephropathy (IgA) is one of the most common glomerulonephritis. Renal transplantation is the treatment of choice for patients with ESRD due to any kind of glomerulopathy, including IgA...
5.
Oliveras A, Vazquez S, Hurtado S, Vila J, Puig J, Lloveras J
Transplant Proc
. 2004 Jul;
36(5):1352-4.
PMID: 15251330
Background: Hypertension (HT) accounts for nearly 60% to 80% of renal transplant patients (RT). It is one of the most important risk factors for cardiovascular diseases and may cause chronic...
6.
Oliveras A, Hurtado S, Vazquez S, Puig J, Lloveras J
Transplant Proc
. 2003 Sep;
35(5):1732-5.
PMID: 12962775
Background: Hypertension (HT), a prevalent complication in renal transplant patient (RT), must be accurately treated because cardiovascular disease is the leading cause of death and of chronic graft dysfunction. Sympathetic...
7.
Soler M, Puig J, Mir M, Parrilla J, Pedro C, Salar A, et al.
Transplant Proc
. 2003 Sep;
35(5):1709-13.
PMID: 12962767
Unlabelled: Posttransplant lymphoproliferative disorders (PTLD) are a heterogeneous group of lymphoid diseases that occur after solid organ and bone marrow transplantation. We performed a retrospective study to assess the incidence,...
8.
Rengel M, Fernandez Rodriguez A, Gomez Huertas E, Plaza J, Ruiz San Millan J, Oppenheimer F, et al.
Transplant Proc
. 2003 Sep;
35(5):1691-3.
PMID: 12962760
Objective: The objective of this study is to assess a Simulect (basiliximab) regimen in routine clinical practice in the Spanish kidney transplantation units to evaluate efficacy and safety. Methods: In...
9.
Puig J, Sola R, Vela E, Cleries M, Lloveras J
Transplant Proc
. 2001 Mar;
33(1-2):1141-3.
PMID: 11267227
No abstract available.
10.
Puig J, Fernandez-Crespo P, Lloveras J, Mir M, Inigo V, Manresa J, et al.
Transplant Proc
. 1999 Sep;
31(6):2270-1.
PMID: 10500572
No abstract available.